InvestorsHub Logo
Followers 260
Posts 18196
Boards Moderated 0
Alias Born 01/19/2006

Re: chickpea598 post# 36386

Saturday, 10/22/2016 8:17:38 PM

Saturday, October 22, 2016 8:17:38 PM

Post# of 48316
The info you recite have been the reasons I have been invested for years with ONCS. But nothing you say dispels my initial rationale why MRK's mono therapy may not be satisfactory for any and all therapy, because not all patients have the particular target Keytruda is aimed at. We await results, eh?